Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-28

FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA Supplemental Approval for INVOKAMET (canagliflozin and metformin hydrochloride) by Janssen Pharmaceuticals, Inc. The action approves a label supplement for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Invokamet (canagliflozin and metformin hydrochloride)

Snippet

SUPPL AP for INVOKAMET (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)